Most People With Stage 3a Chronic Kidney Disease Will Never Need Dialysis
Stage 3a CKD means your kidneys are filtering blood at a moderately reduced rate, with an estimated glomerular filtration rate (eGFR) between 45 and 59 mL/min/1.73 m². That number has to persist for at least three months to count as CKD rather than a temporary dip. If your doctor just flagged this on your bloodwork, the single most important thing to understand is that your urine albumin level matters as much as, or more than, the eGFR number itself.
What the Numbers Actually Mean
Your eGFR is a calculation based on your blood creatinine level (and sometimes a protein called cystatin C), using formulas like CKD-EPI that estimate how well your kidneys are filtering waste. It's not a direct measurement. It's an estimate, and the newer CKD-EPI equation does a better job of sorting risk than older formulas.
But eGFR alone doesn't tell the full story. The other critical number is your urine albumin-to-creatinine ratio (uACR), which measures how much protein is leaking into your urine. This gets classified into three categories:
- A1: Normal to mildly increased albumin
- A2: Moderately increased
- A3: Severely increased
The combination of eGFR and uACR together determines your actual risk profile far more accurately than either number alone.
The Albumin Number That Changes Everything
Here's where stage 3a CKD gets genuinely interesting. In studies of people with diabetes and stage 3a CKD, only about 1 to 3% of those with normal or mildly increased urine albumin (A1 or A2) progressed to stage 5 (the point where dialysis becomes a conversation) over five years. For those with severely increased albumin (A3), that number jumped to roughly 15%.
That's a massive difference. Same eGFR range, wildly different outcomes based on what's happening with urine protein.
| Albumin Category | Urine Albumin Level | 5-Year Progression to Stage 5 (in diabetes) |
|---|---|---|
| A1/A2 | Normal to moderately increased | ~1–3% |
| A3 | Severely increased | ~15% |
If you're sitting in stage 3a with A1 or A2 albumin levels, your odds of ever needing dialysis are low. If you're in A3 territory, the urgency of treatment goes up considerably.
The Cardiovascular Risk You Didn't Expect
Kidney disease isn't just about kidneys. Even in the 45 to 59 eGFR range, cardiovascular and mortality risk starts climbing compared to people with normal kidney function. This is especially true for younger adults and women.
This means a stage 3a CKD diagnosis isn't just a kidney conversation. It's a heart conversation. The research points to blood pressure control, statin use, and diabetes management as the cornerstones of reducing that cardiovascular risk, not just slowing kidney decline.
Why So Many Cases Go Unnoticed
Stage 3a CKD often produces no symptoms. You feel fine. Your doctor may not have flagged it. Across multiple countries, research shows that 60 to 95% of people with repeated eGFR values between 30 and 59 had no CKD diagnosis code in their medical records.
Under-diagnosis is most common in:
- Stage 3a (versus more advanced stages)
- Women
- Older adults
This matters because early identification changes outcomes. Data from China showed that when CKD was caught early, patients were more likely to receive kidney-protective medications and experienced slower eGFR decline over time.
Where Stage 3a Fits in the Bigger Picture
| CKD Stage | eGFR Range | Risk Profile |
|---|---|---|
| 3a | 45–59 | Moderate CKD. Cardiovascular risk rises. Progression depends heavily on albuminuria and other conditions. |
| 3b | 30–44 | Higher risk of kidney failure, death, and complications |
| 4–5 | Below 30 | High risk of dialysis and severe complications |
Stage 3a is a real diagnosis with real implications, but it sits at a point where intervention has the most leverage. You're far enough along that risk is elevated, but early enough that the right actions can meaningfully change the trajectory.
What Actually Slows Progression
The research identifies a clear set of management priorities for stage 3a CKD:
- Blood pressure control, often with RAAS blockers (medications that target the renin-angiotensin-aldosterone system, a hormonal pathway that regulates blood pressure and fluid balance)
- Diabetes management if applicable
- Statin therapy for cholesterol and cardiovascular protection
- Regular monitoring of both eGFR and uACR over time to track whether kidney function is stable or declining
The emphasis on monitoring isn't just box-checking. Trends in your eGFR and albumin levels over months and years tell your doctor far more than any single lab draw.
A Practical Framework for What to Do Next
If you've been told your eGFR is between 45 and 59, here's how to think about your situation:
- If your urine albumin is normal or mildly increased (A1/A2): Your near-term risk of kidney failure is low. Focus on cardiovascular risk reduction: blood pressure, cholesterol, blood sugar if diabetic. Get your eGFR and uACR rechecked on whatever schedule your doctor recommends.
- If your urine albumin is severely increased (A3): Your progression risk is meaningfully higher. Aggressive management of blood pressure (ask specifically about RAAS blockers), diabetes, and cholesterol becomes more urgent. Closer monitoring intervals make sense.
- If you don't know your urine albumin level: Ask for a uACR test. An eGFR number without a uACR is an incomplete picture. Given how common under-diagnosis is in this stage, it's worth confirming that someone is actually tracking both numbers over time rather than letting a mildly abnormal eGFR slip through the cracks.
